Table 2 Change in claims for non-opioid pain medications, weak opioids, and strong opioids between 2006 and 2013

Non-opioids

2006

2013

% Diff 06-13

Number of persons^a:

455'845

501'996

10

Age: median (IQR)

47 (41)

48 (41)

Female: n (%)

265'135 (58.2)

288'289 (57.4)

Number of claims: n

1'342'454

1'657'420

23

Number of claims / person

2.94

3.3

12

Paracetamol: number of claims

512'762

639'716

25

Metamizole: number of claims

55'000

185'168

237

NSAID^b: number of claims

174'293

329'075

89

Coxibs: number of claims

22'809

39'743

74

Paracematol: claims / 100'000

40'211

53'062

32

Metamizole: claims / 100'000

4'018

13'729

242

NSAID + Coxibs claims / 100'000

15'634

31'995

105

NSAID claims / 100'000

1'049'968

2'354'922

124

Coxibs claims / 100'000

123'981

249'306

101

Ibuprofen: claims / 100'000

235

395

68

Paracetamol: 1000 mg / 100'000

1'116'931

2'717'129

143

Metamizole: 1000 mg / 100'000

61'074

501'196

721

Weak opioids

2006

2013

% Diff 06-13

Number of persons^a

53'786

55'604

3

Age: median (IQR)

61 (29)

62 (30)

Female: n (%)

33'172 (62)

33'629 (60)

Number of claims#: n

160'517

167'278

4

Number of claims / person

2.98

3.01

1

Number of claims / 100'000

11'957

13'348

13

Total MED in mg

50'339

57'782

15

Total MED in mg/Person

936

1'039

11

Total MED in 1000 mg/ 100'000

3'768

4'655

24

Tramadol in MED 1000 mg/ 100'000

3'046

3'750

23

Codeine MED in 1000 mg/ 100'000

722

587

−19

Tapentadol MED in 1000 mg / 100'000

-

317

-

Strong opioids

2006

2013

% Diff 06-13

Number of persons^a

16'744

28'509

70

Age: median (IQR)

66 (27)

69 (29)

Female: n (%)

10'297 (62)

17'570 (62)

Number of claims: n

64'839

137'458

112

Number of claims / person

3.87

4.82

25

Number of claims / 100'000

4'716

10'419

121

Total MED 1000 mg

146'151

294'320

101

Total MED in mg/Person

8'729

10'324

18

Total treatment days

1'199

2'274

90

Total treatment days/ person

72

80

11

Total MED in 1000 mg/ 100'000

11'011

23'854

117

Total treatment days / 100'000

89'903

180'371

101

Total MED / treatment day

121.9

129.4

6

Morphine: MED 1000 mg / 100'000

2'875

4'648

62

Oxycodone and comb: MED 1000 mg / 100'000

1'237

5'110

313

Fentanyl: MED 1000 mg / 100'000

3'588

6'851

91

Pethidine: MED 1000 mg / 100'000

33

39

18

Hydromorphone: MED 1000 mg / 100'000

548

730

33

Methadone: MED 1000 mg / 100'000

28

424

1414

Buprenorphine: MED 1000 mg / 100'000

2'699

6'049

124

Nalbuphine: MED 1000 mg / 100'000

2

2

0

Morphine: treatment days / 100'000

28'988

46'856

62

Oxycodone: treatment days / 100'000

10'994

45'422

313

Fentanyl: treatment days / 100'000

29'941

57'953

94

Pethidine: treatment days / 100'000

411

491

19

Hydromorphone: treatment days / 100'000

3'657

4'988

36

Methadone: treatment days / 100'000

373

5'645

1413

Buprenorphine: treatment days / 100'000

15'509

18'985

22

Nalbuphine: treatment days / 100'000

31

30

−3

Oral long acting: MED 1000 mg / 100'000

4'409

9'761

121

Oral short acting: MED 1000 mg / 100'000

142

865

509

Parenteral: MED 1000 mg / 100'000

168

328

95

Rectal: MED 1000 mg / 100'000

5

9

80

Sublingual: MED 1000 mg / 100'000

1'243

4'986

301

Transdermal: MED 1000 mg / 100'000

5'045

7'905

57